Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Therapy Versus Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Randomized Trial

NCT02635191 is registered in ClinicalTrials.gov with Beijing Children's Hospital as lead sponsor.

NCT NCT02635191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02635191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Therapy Versus Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Randomized Trial
Lead sponsor
Beijing Children's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2014
Completion date
July 31, 2016
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection